Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Pariente
Edouard Louis

Showing results (81-90 of 364) with videos related to

Pageof 37
Sort By:
AJR. American Journal of Roentgenology|June 25, 2011
Gastroenterology review and perspective: the role of cross-sectional imaging in evaluating bowel damage in Crohn diseaseBenjamin Pariente, Laurent Peyrin-Biroulet, Louis Cohen, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 10, 2018
Allogeneic mesenchymal stromal cells for refractory luminal Crohn's disease: A phase I-II studyCéline Gregoire, Alexandra Briquet, Caroline Pirenne, et al.
Journal of Crohn'S & Colitis|September 21, 2022
Patients with Inflammatory Bowel Disease Have Heterogeneous Treatment Preferences That Are Largely Determined by the Avoidance of Abdominal Pain and Side Effects [P-POWER IBD Study]Edouard Louis, Corey A Siegel, Barbara James, et al.
Digestive Diseases (Basel, Switzerland)|January 9, 2013
Deep remission: a new concept?Jean-Frédéric Colombel, Edouard Louis, Laurent Peyrin-Biroulet, et al.
Journal of Clinical Medicine|September 1, 2019
Exosomal miRNAs in Lung Diseases: From Biologic Function to Therapeutic TargetsJulien Guiot, Ingrid Struman, Edouard Louis, et al.
Inflammatory Bowel Diseases|April 20, 2013
Evolving definitions of remission in Crohn's diseaseRemo Panaccione, Jean-Frédéric Colombel, Edouard Louis, et al.
The Lancet. Gastroenterology & Hepatology|December 11, 2019
De-escalation of immunomodulator and biological therapy in inflammatory bowel diseaseThomas P Chapman, Catarina Frias Gomes, Edouard Louis, et al.
Alimentary Pharmacology & Therapeutics|October 21, 2020
Letter: rationalising aminosalicylates in inflammatory bowel disease-authors' replyThomas P Chapman, Catarina Frias Gomes, Edouard Louis, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 8, 2021
Fistulizing perianal lesions in a French population with Crohn's diseasePauline Wils, Ariane Leroyer, Mathurin Fumery, et al.
Scandinavian Journal of Gastroenterology|December 19, 2022
Factors associated with the efficacy and safety of endoscopic dilatation of symptomatic strictures in Crohn's disease: a retrospective cohort studyPierre Dandoy, Edouard Louis, Pierrette Gast, et al.
Pageof 37

Showing results (81-90 of 364) with videos related to

Sort By:
Pageof 37
AJR. American Journal of Roentgenology|June 25, 2011
Gastroenterology review and perspective: the role of cross-sectional imaging in evaluating bowel damage in Crohn diseaseBenjamin Pariente, Laurent Peyrin-Biroulet, Louis Cohen, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 10, 2018
Allogeneic mesenchymal stromal cells for refractory luminal Crohn's disease: A phase I-II studyCéline Gregoire, Alexandra Briquet, Caroline Pirenne, et al.
Journal of Crohn'S & Colitis|September 21, 2022
Patients with Inflammatory Bowel Disease Have Heterogeneous Treatment Preferences That Are Largely Determined by the Avoidance of Abdominal Pain and Side Effects [P-POWER IBD Study]Edouard Louis, Corey A Siegel, Barbara James, et al.
Digestive Diseases (Basel, Switzerland)|January 9, 2013
Deep remission: a new concept?Jean-Frédéric Colombel, Edouard Louis, Laurent Peyrin-Biroulet, et al.
Journal of Clinical Medicine|September 1, 2019
Exosomal miRNAs in Lung Diseases: From Biologic Function to Therapeutic TargetsJulien Guiot, Ingrid Struman, Edouard Louis, et al.
Inflammatory Bowel Diseases|April 20, 2013
Evolving definitions of remission in Crohn's diseaseRemo Panaccione, Jean-Frédéric Colombel, Edouard Louis, et al.
The Lancet. Gastroenterology & Hepatology|December 11, 2019
De-escalation of immunomodulator and biological therapy in inflammatory bowel diseaseThomas P Chapman, Catarina Frias Gomes, Edouard Louis, et al.
Alimentary Pharmacology & Therapeutics|October 21, 2020
Letter: rationalising aminosalicylates in inflammatory bowel disease-authors' replyThomas P Chapman, Catarina Frias Gomes, Edouard Louis, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 8, 2021
Fistulizing perianal lesions in a French population with Crohn's diseasePauline Wils, Ariane Leroyer, Mathurin Fumery, et al.
Scandinavian Journal of Gastroenterology|December 19, 2022
Factors associated with the efficacy and safety of endoscopic dilatation of symptomatic strictures in Crohn's disease: a retrospective cohort studyPierre Dandoy, Edouard Louis, Pierrette Gast, et al.
Pageof 37